Document ID: chunk:federal_register_of_legislation:F2021L00608:clause:1_1
Version: federal_register_of_legislation:F2021L00608
Segment Type: clause
Provision Reference: sch 1 cl 1
Character Range: 6955–8513

1               Definitions
In this instrument:
                                  biologic agent means a therapeutic product which is derived from living organisms or which contains components of living organisms.
        Note: Examples of biologic agents that have been associated with transverse myelitis include tyrosine kinase inhibitors, immune checkpoint inhibitors and dinutuximab.
                                  MRCA means the Military Rehabilitation and Compensation Act 2004.
                                  relevant service means:
(a)          eligible war service (other than operational service) under the VEA;
(b)          defence service (other than hazardous service and British nuclear test defence service) under the VEA; or
(c)          peacetime service under the MRCA.
Note: MRCA and VEA are also defined in the Schedule 1 - Dictionary.
                                  specified list of drugs means:
(a)          biologic agents for the treatment of cancer; or
(b)          tumour necrosis factor-α inhibitors.
Note: biologic agent is also defined in the Schedule 1 - Dictionary.
                                  terminal event means the proximate or ultimate cause of death and includes the following:
(a)           pneumonia;
(b)           respiratory failure;
(c)           cardiac arrest;
(d)           circulatory failure; or
(e)           cessation of brain function.
                                  transverse myelitis—see subsection 6(2).
                                  VEA means the Veterans' Entitlements Act 1986.